Laboratory of Cardiovascular Immunology, Institute of Cardiology, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
J Clin Immunol. 2010 Mar;30(2):226-34. doi: 10.1007/s10875-009-9355-z. Epub 2009 Dec 10.
Recently, the Th17 cell, a newly determined CD4+Th subset, was reported to participate in the inflammation of myocarditis combined with Th1 cells, and this study aimed to explore whether it was involved in the Th2 cell-mediated humoral immunity in viral myocarditis.
A total of 34 patients, including 16 acute viral myocarditis (AVMC) and 18 dilated cardiomyopathy (DCM) having a history of AVMC, were enrolled for this study besides 18 healthy volunteers.
The frequencies of Th17 and Th1 cells, especially Th17 cells in AVMC patients, while those of Th1 and Th2 cells, especially Th2 cells in DCM group, were all increased significantly compared with those in healthy volunteers (P < 0.01), with no changes of Th2 cells in AVMC and Th17 cells in DCM groups. The similar results were also observed in Th cell cytokines (IL-17, INF-gamma, and IL-4) and key transcript factors (RORgammat, T-bet, and GATA-3). Meanwhile, antiheart antibodies (AHA) of IgG type were found in 15 (93.8%) patients with AVMC and ten (55.6%) cases with DCM, accompanied by the higher expression of IL-17R on B cells and the frequencies of B cells than those in healthy controls (P < 0.01 in AVMC and P < 0.05 in DCM, respectively) who had no AHA. Furthermore, both of the B cell activities in AVMC and DCM groups were elevated and positively correlated to serum IL-17 (R = 0.66, P < 0.01) and IL-4 (R = 0.47, P < 0.05) respectively, with no correlation to INF-gamma.
It was Th17 cells but not Th2 cells that helped the B cells to produce AHA in AVMC and not until at the late phase of viral myocarditis could Th2 cells play the important role in mediating humoral response.
最近,新确定的 CD4+Th 亚群 Th17 细胞被报道参与合并 Th1 细胞的心肌炎炎症,本研究旨在探讨其是否参与病毒性心肌炎的 Th2 细胞介导的体液免疫。
共纳入 34 例患者,包括 16 例急性病毒性心肌炎(AVMC)和 18 例有 AVMC 病史的扩张型心肌病(DCM),另外还纳入 18 例健康志愿者。
与健康志愿者相比,AVMC 患者 Th17 和 Th1 细胞(尤其是 AVMC 患者的 Th17 细胞)以及 DCM 组 Th1 和 Th2 细胞(尤其是 DCM 组的 Th2 细胞)的频率均显著升高(P < 0.01),而 AVMC 组的 Th2 细胞和 DCM 组的 Th17 细胞没有变化。在 Th 细胞细胞因子(IL-17、INF-γ 和 IL-4)和关键转录因子(RORgammat、T-bet 和 GATA-3)中也观察到了类似的结果。同时,在 15 例(93.8%)AVMC 患者和 10 例(55.6%)DCM 患者中发现 IgG 型抗心肌抗体(AHA),且 B 细胞上的 IL-17R 表达和 B 细胞频率均高于健康对照组(P < 0.01,在 AVMC 中;P < 0.05,在 DCM 中),健康对照组无 AHA。此外,AVMC 和 DCM 组的 B 细胞活性均升高,与血清 IL-17(R = 0.66,P < 0.01)和 IL-4(R = 0.47,P < 0.05)呈正相关,与 INF-γ无关。
是 Th17 细胞而不是 Th2 细胞帮助 AVMC 中的 B 细胞产生 AHA,只有在病毒性心肌炎的晚期,Th2 细胞才能在介导体液反应中发挥重要作用。